Florian Heubach
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
DECODE VRL Report No. 1: Lymphocyte Survival After Diagnostic Vitrectomy - Does Size Matter?
Journal: Translational vision science & technology
Published: January 27, 2026
Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
Journal: Cancer immunology, immunotherapy : CII
Published: July 18, 2023
Targeting GD2 after allogeneic SCT: effector cell composition defines the optimal use of ch14.18 and the bispecific antibody construct NG-CU (GD2-CD3).
Journal: Cancer immunology, immunotherapy : CII
Published: May 11, 2023
Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.
Journal: Haematologica
Published: August 25, 2022
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
Journal: Frontiers in immunology
Published: April 02, 2021
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity.
Journal: Bone marrow transplantation
Published: August 22, 2019
ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL.
Journal: Bone marrow transplantation
Published: August 22, 2019
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 14, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026